Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 373-379, March 2010

Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus

  • Nikolaos P.E. Kadoglou

      Affiliations

    • First Department of Internal Medicine, “Hippokratio” General Hospital of Thessaloniki, Greece
    • Biomedical Research Foundation, Center of Experimental Surgery, Academy of Athens, Greece
    • Corresponding Author InformationCorresponding author. 124 Vosporou str, GR-54454 Thessaloniki, Greece. Tel.: +30 2310905178; fax: +30 2310905178.
    • ,
  • Hercules Tsanikidis

      Affiliations

    • Diabetic Outpatients' Department, General Hospital of Katerini, Greece
    • ,
  • Alkistis Kapelouzou

      Affiliations

    • Biomedical Research Foundation, Center of Experimental Surgery, Academy of Athens, Greece
    • ,
  • Ioannis Vrabas

      Affiliations

    • Department of Physical Education and Sports Sciences (Serres), Aristotle University of Thessaloniki, Greece
    • ,
  • Ioulia Vitta

      Affiliations

    • First Department of Internal Medicine, “Hippokratio” General Hospital of Thessaloniki, Greece
    • ,
  • Panayotis E. Karayannacos

      Affiliations

    • Biomedical Research Foundation, Center of Experimental Surgery, Academy of Athens, Greece
    • ,
  • Christos D. Liapis

      Affiliations

    • Department of Vascular Surgery, Medical School, University of Athens, Greece
    • ,
  • Nikolaos Sailer

      Affiliations

    • First Department of Internal Medicine, “Hippokratio” General Hospital of Thessaloniki, Greece

Received 17 March 2009; accepted 7 August 2009. published online 08 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 ClinicalTrials.gov identifier: NCT00373178.

PII: S0026-0495(09)00329-1

doi:10.1016/j.metabol.2009.08.005

Metabolism - Clinical and Experimental
Volume 59, Issue 3 , Pages 373-379, March 2010

Article Tools

* Image Usage & Resolution